This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Common Services Agency. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Brenda Doreen Griffin: Innovator in Prion Infectivity Removal
Introduction
Brenda Doreen Griffin is a notable inventor based in Edinburgh, GB. She has made significant contributions to the field of biomedical research, particularly in the area of prion infectivity.
Latest Patents
Brenda holds a patent for the "Removal of prion infectivity." This innovative method involves the removal of prion infectivity adsorbed onto substrates, such as chromatographic columns used to fractionate blood plasma, through treatment with 2M sodium chloride. Additionally, the substrate can be further washed with 0.1 M sodium hydroxide to enhance the removal process.
Career Highlights
Brenda is associated with the Common Services Agency, where she applies her expertise in prion research. Her work has implications for public health and safety, particularly in the context of infectious diseases.
Collaborations
Brenda has collaborated with notable colleagues, including Peter Reynolds Foster and Ronald Vance McIntosh. These partnerships have contributed to her research and the advancement of her patented methods.
Conclusion
Brenda Doreen Griffin's innovative work in prion infectivity removal showcases her dedication to improving biomedical practices. Her contributions are vital in the ongoing fight against infectious diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile